(Q33337233)

25 July 2017

title

A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma (English)

1 reference

multicenter clinical trial

25 July 2017

main subject

0 references

1 reference

A Khorana

1

1 reference

25 July 2017

P Bunn

2

1 reference

25 July 2017

P McLaughlin

3

1 reference

25 July 2017

J Vose

4

1 reference

25 July 2017

C Stewart

5

1 reference

25 July 2017

M S Czuczman

6

1 reference

25 July 2017

language of work or name

1 reference

1 March 2001

1 reference

25 July 2017

1 reference

25 July 2017

volume

41

1 reference

25 July 2017

issue

1-2

1 reference

25 July 2017

page(s)

77-87

1 reference

25 July 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057956

Clinical highlights from the National Cancer Data Base, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057956

Reshaping human antibodies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057956

Immunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057956

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057956

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057956

Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109057956

10.3109/10428190109057956

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference